Background The COVID-19 pandemic heightened risks for individuals with hematological
malignancies due to compromised immune systems, leading to more severe outcomes and …

Background. Critical and progressive cachexia may be observed in numerous medical
disciplines, but in patients with various diseases, several pathways overlap (endocrine …

In the past 25 years, the world has witnessed outbreaks of illnesses in humans from three
different coronaviruses. Both the SARS-CoV outbreak of 2003 and the MERS-CoV outbreak …

Patients with hematologic malignancies are at increased risk of adverse COVID‐19
outcomes; nonetheless, only sparse population‐based data are available on mortality …

Introduction Critically ill patients are more susceptible to malnutrition due to their severe
illness. Moreover, elderly patients who are critically ill lack specific nutrition …

While COVID-19 becomes periodical, old individuals remain vulnerable to severe disease
with high mortality. Although there have been some studies on revealing different risk factors …

Objectives Despite high global vaccination coverage, it remains unclear how vaccination
and anti-SARS-CoV-2 antibodies affect immune responses and inflammation levels in …

Community‐acquired respiratory viral infections (CARV) significantly impact patients with
hematological malignancies (HM), leading to high morbidity and mortality. However, large …

Objectives: Despite the currently prevailing, milder Omicron variant, coronary artery disease
(CAD) patients constitute a major risk group in COVID-19, exhibiting 2.6 times the mortality …

We emulated a hypothetical target trial in which hematological subjects cared at the
University Hospital of Pisa (Italy) received or not SARS-CoV-2 prophylaxis with tixagevimab …